Delivery Order SPE2DR25D1017-SPE2DR26F9BLM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,843.56 to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Quelipat 60 mg tablets (30-count packaging). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and requires ultimate completion by November 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents one of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,551.70 by the Defense Logistics Agency on December 9, 2025, for the supply of Qualiptá 60 mg tablets in a quantity of 30 units. This firm fixed price delivery order, with an ultimate completion date of December 10, 2025, represents a non-competitive set-aside contract and will be performed at the vendor's Conshohocken facility. The award falls...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,885.59 on December 12, 2025, for the supply of Qualiptia 60 mg tablets (30-count packaging), with an ultimate completion date of December 15, 2025. This firm fixed-price delivery order represents a non-competitive award and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The award is classified as a child contract under a larger contract vehicle, leveraging...
- The Defense Logistics Agency awarded a $26,473.25 delivery order to AmerisourceBergen Drug Corp for Qualipta 60 mg tablets (30-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $19,731.24 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, with performance at its corporate office location. This firm fixed price delivery order, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made...
- The Defense Logistics Agency awarded a delivery order valued at $14,920.38 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, with a firm fixed price contract type. This delivery order, issued on December 12, 2025, with an ultimate completion date of January 6, 2026, represents a child contract under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The award carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order valued at $1,873.41 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on November 14, 2025, with a completion date of November 17, 2025. This firm fixed-price delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,474.22 by the Defense Logistics Agency's Medical Supply Chain on December 3, 2025, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract reflecting the contractor's established capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $17,298.18 to AmerisourceBergen Drug Corp for pharmaceutical products and supplies under a firm fixed price contract structure. This non-set-aside delivery order, issued on December 10, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery vehicle with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $12,270.28 to AmerisourceBergen Drug Corp on December 13, 2025, with completion scheduled for December 15, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor's Corporate Office division. The work will be performed at AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This delivery order is a...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BLMDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,226.74 for 30 tablets of Quelipra 60 mg on December 15, 2025, with completion scheduled for December 16, 2025. This firm fixed-price contract represents a non-competitive delivery order executed under the company's existing indefinite delivery vehicle with DLA. The award is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is a child contract under AmerisourceBergen's larger $999.999 billion Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which runs through December 2026 and serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen's federal contracting portfolio demonstrates extensive capability in supplying specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The non-set-aside designation reflects the company's competitive standing and ability to fulfill federal pharmaceutical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.2k | 12/14/25 |